1897 RAD001, A mTOR specificity inhibitor, combined with PI3K Inhibitor LY294002, significantly reduced proliferation and induced apoptosis of triple negative breast cancer cell lines MDA-MB-231 through PI3K/Akt/mTOR pathway in vitro. (September 2015) - Sun, G.; Ma, B.; Yang, L.; Dong, C.; Ma, B.